Prescribing Practices of Recommended Treatment for Trichomonas vaginalis and Chlamydia trachomatis After 2021 Sexually Transmitted Infection Treatment Guideline Update

Sex Transm Dis. 2024 Nov 1;51(11):e40-e42. doi: 10.1097/OLQ.0000000000001987. Epub 2024 May 6.

Abstract

We evaluated the proportion of patients with trichomoniasis and chlamydial infections who received recommended versus nonrecommended antibiotic therapy after the updated 2021 Sexually Transmitted Infections Guideline. Of 712 patients, 473 (66%) received recommended therapy. Receipt of emergency department care was independently associated with recommended therapy (adjusted odds ratio, 2.1; 95% confidence interval, 1.5-2.9).

MeSH terms

  • Adolescent
  • Adult
  • Anti-Bacterial Agents* / administration & dosage
  • Anti-Bacterial Agents* / therapeutic use
  • Chlamydia Infections* / drug therapy
  • Chlamydia trachomatis*
  • Female
  • Guideline Adherence
  • Humans
  • Male
  • Practice Guidelines as Topic*
  • Practice Patterns, Physicians' / standards
  • Practice Patterns, Physicians' / statistics & numerical data
  • Sexually Transmitted Diseases / drug therapy
  • Trichomonas Infections* / drug therapy
  • Trichomonas Vaginitis / drug therapy
  • Trichomonas vaginalis* / drug effects
  • Trichomonas vaginalis* / isolation & purification
  • Young Adult

Substances

  • Anti-Bacterial Agents